Stay updated with breaking news from Brad Margus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Consortium to advance R&D towards disease modifying drugs for fatal neurodegenerative pediatric diseases driven by inability to repair DNA damage A-T Children's Project, AT Society and Action
NEW HAVEN, Conn., Dec. 16, 2022 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs...
In phase 2 trials, the drug reduced ‘OFF time’ which refers to periods of the day when Parkinson’s symptoms recur despite medication - News - PharmaTimes
Press release content from Globe Newswire. The AP news staff was not involved in its creation. Cerevance Appoints Carrie Ann Cook As Chief Business Officer CerevanceFebruary 1, 2021 GMT BOSTON, Feb. 01, 2021 (GLOBE NEWSWIRE) -- Cerevance, a private drug discovery and development company focused on brain diseases, today announced the appointment of Carrie Ann Cook, a global business development executive with more than 20 years of experience in the pharmaceutical industry, as chief business officer effective February 1, 2021. Ms. Cook most recently served as senior vice president/global h...